| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |